Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Nova Mentis Life Science Corp (NOVA.CN)

Nova Mentis Life Science Corp (NOVA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nova Mentis Life Science Corp 700-838 West Hastings Street Vancouver BC V6C 0A6 CAN

https://www.novamentis.ca P: 778-819-0244

Description:

Nova Mentis Life Science Corp is a Canadian-based biotechnology company. It is engaged in developing diagnostics and psilocybin-based therapeutics for neuroinflammatory disorders. Nova uses psilocybin in the treatment of Fragile X Syndrome (FXS). The company's goal is to diagnose and treat debilitating chronic conditions that have unmet medical needs such as autism spectrum disorder (ASD) and FXS. It has one industry segment, being research and development of psilocybin, and in one geographic area, which is Canada.

Key Statistics

Overview:

Market Capitalization, $K 2,208
Shares Outstanding, K 147,169
Annual Sales, $ 0 K
Annual Net Income, $ -2,466 K
Last Quarter Sales, $ 28 K
Last Quarter Net Income, $ -184 K
60-Month Beta -2.37
% of Institutional Shareholders 2.93%

Growth:

1-Year Return -72.73%
3-Year Return -84.21%
5-Year Return -87.50%
5-Year Revenue Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Year -21.57%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 06/26/20

NOVA.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,249.37%
Return-on-Assets % -343.51%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales 77.11
Price/Book N/A
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar